Comparison of patient exit interviews with unannounced standardised patients for assessing HIV service delivery in Zambia: a study nested within a cluster randomised trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
05 07 2023
Historique:
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

To compare unannounced standardised patient approach (eg, mystery clients) with typical exit interviews for assessing patient experiences in HIV care (eg, unfriendly providers, long waiting times). We hypothesise standardised patients would report more negative experiences than typical exit interviews affected by social desirability bias. Cross-sectional surveys in 16 government-operated HIV primary care clinics in Lusaka, Zambia providing antiretroviral therapy (ART). 3526 participants aged ≥18 years receiving ART participated in the exit surveys between August 2019 and November 2021. Systematic sample (every n We compared patient experience among patients who received brief training prior to their care visit (explaining each patient experience construct in the exit survey, being anonymous, without manipulating behaviour) with those who did not undergo training on the survey prior to their visit. Among 3526 participants who participated in exit surveys, 2415 were untrained (56% female, median age 40 (IQR: 32-47)) and 1111 were trained (50% female, median age 37 (IQR: 31-45)). Compared with untrained, trained patients were more likely to report a negative care experience overall (adjusted prevalence ratio (aPR) for aggregate sum score: 1.64 (95% CI: 1.39 to 1.94)), with a greater proportion reporting feeling unwelcome by providers (aPR: 1.71 (95% CI: 1.20 to 2.44)) and witnessing providers behaving rude (aPR: 2.28 (95% CI: 1.63 to 3.19)). Trained patients were more likely to identify suboptimal care. They may have understood the items solicited better or felt empowered to be more critical. We trained existing patients, unlike studies that use 'standardised patients' drawn from outside the patient population. This low-cost strategy could improve patient-centred service delivery elsewhere. Assessment was nested within a parent study; www.pactr.org registered the parent study (PACTR202101847907585).

Identifiants

pubmed: 37407057
pii: bmjopen-2022-069086
doi: 10.1136/bmjopen-2022-069086
pmc: PMC10335575
doi:

Banques de données

PACTR
['PACTR202101847907585']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e069086

Subventions

Organisme : Bill & Melinda Gates Foundation
ID : INV-010563
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI134413
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002346
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

PLoS Med. 2020 May 13;17(5):e1003107
pubmed: 32401797
PLoS One. 2021 Mar 3;16(3):e0247259
pubmed: 33657153
AIDS. 2016 Jan 28;30(3):495-502
pubmed: 26765940
PLoS One. 2018 Mar 14;13(3):e0193641
pubmed: 29538443
BMJ Glob Health. 2021 May;6(5):
pubmed: 33990360
J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S120-6
pubmed: 22797733
PLoS Med. 2019 May 31;16(5):e1002811
pubmed: 31150380
Int J Qual Health Care. 2011 Feb;23(1):76-82
pubmed: 21131382
PLoS Med. 2018 Jan 12;15(1):e1002489
pubmed: 29329301
J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):62-72
pubmed: 33105396
Health Aff (Millwood). 2013 Feb;32(2):207-14
pubmed: 23381511
PLoS Med. 2020 Feb 14;17(2):e1003028
pubmed: 32059023
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):147-152
pubmed: 33136818
AIDS Res Treat. 2013;2013:706191
pubmed: 23476754
BMJ Glob Health. 2021 Apr;6(4):
pubmed: 33893142
PLoS Med. 2018 Aug 13;15(8):e1002636
pubmed: 30102693
BMJ Glob Health. 2018 Oct 25;3(5):e001007
pubmed: 30483408
Health Policy Plan. 2019 Oct 1;34(8):625-634
pubmed: 31424494
Clin Infect Dis. 2021 Oct 5;73(7):e2294-e2302
pubmed: 33011803
Reprod Health. 2019 May 29;16(Suppl 1):61
pubmed: 31138307
BMC Health Serv Res. 2014 Apr 05;14:157
pubmed: 24708683
BMJ Open. 2020 Jun 21;10(6):e035689
pubmed: 32565464
Int J Qual Health Care. 2002 Dec;14 Suppl 1:17-24
pubmed: 12572784
Med Educ. 2009 Jun;43(6):521-5
pubmed: 19493175
BMJ Glob Health. 2017 Jun 10;2(2):e000333
pubmed: 29225937
Med Educ. 2007 Feb;41(2):123-9
pubmed: 17269944
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
BMJ. 2002 Sep 28;325(7366):679
pubmed: 12351358
AIDS Behav. 2021 May;25(5):1384-1395
pubmed: 32748158
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
BMJ Glob Health. 2019 Sep 12;4(5):e001669
pubmed: 31565413
J Acquir Immune Defic Syndr. 2010 Mar;53(3):405-11
pubmed: 19745753
BMC Health Serv Res. 2020 May 26;20(1):473
pubmed: 32456633
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
AIDS Care. 2021 Feb;33(2):154-158
pubmed: 31847544
AIDS Patient Care STDS. 2000 Apr;14(4):189-97
pubmed: 10806637
J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25120
pubmed: 30027651
J Clin Psychol Med Settings. 2010 Jun;17(2):125-36
pubmed: 20217195
BMC Health Serv Res. 2013 Nov 14;13:476
pubmed: 24229365
J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S230-S243
pubmed: 31764259
Lancet HIV. 2019 Mar;6(3):e191-e200
pubmed: 30777726
J Gen Intern Med. 2014 Aug;29(8):1183-7
pubmed: 24756945
Fam Pract. 1997 Feb;14(1):58-62
pubmed: 9061346

Auteurs

Kombatende Sikombe (K)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia kombatende.sikombe@cidrz.org.
Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine Faculty of Public Health and Policy, London, UK.

Jake M Pry (JM)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Aaloke Mody (A)

Internal Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.

Brian Rice (B)

Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine Faculty of Public Health and Policy, London, UK.

Chama Bukankala (C)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Ingrid Eshun-Wilson (I)

Internal Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.

Jacob Mutale (J)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Sandra Simbeza (S)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Laura K Beres (LK)

Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Njekwa Mukamba (N)

Social and Behavioural Science Research Group, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Mpande Mukumbwa-Mwenechanya (M)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Daniel Mwamba (D)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Anjali Sharma (A)

Social and Behavioural Science Research Group, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Alison Wringe (A)

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.

James Hargreaves (J)

Department of Public Health, Environments and Society, London School of Hygiene and Tropical Medicine Faculty of Public Health and Policy, London, UK.

Carolyn Bolton-Moore (C)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.
Department of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

Charles Holmes (C)

Center for Innovation in Global Health, Georgetown University Medical Center, Washington, District of Columbia, USA.

Izukanji T Sikazwe (IT)

Implementation Science Unit, Center for Infectious Disease Research in Zambia, Lusaka, Zambia.

Elvin Geng (E)

Internal Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH